These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 14514503)

  • 1. Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
    Teipel SJ; Schapiro MB; Alexander GE; Krasuski JS; Horwitz B; Hoehne C; Möller HJ; Rapoport SI; Hampel H
    Am J Psychiatry; 2003 Oct; 160(10):1870-8. PubMed ID: 14514503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia.
    Aylward EH; Li Q; Honeycutt NA; Warren AC; Pulsifer MB; Barta PE; Chan MD; Smith PD; Jerram M; Pearlson GD
    Am J Psychiatry; 1999 Apr; 156(4):564-8. PubMed ID: 10200735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H; Teipel SJ; Alexander GE; Pogarell O; Rapoport SI; Möller HJ
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.
    Huang W; Alexander GE; Daly EM; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
    Am J Psychiatry; 1999 Dec; 156(12):1879-86. PubMed ID: 10588400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small planum temporale volume in Down's syndrome: a volumetric MRI study.
    Frangou S; Aylward E; Warren A; Sharma T; Barta P; Pearlson G
    Am J Psychiatry; 1997 Oct; 154(10):1424-9. PubMed ID: 9326826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroanatomy of Down's syndrome: a high-resolution MRI study.
    Pinter JD; Eliez S; Schmitt JE; Capone GT; Reiss AL
    Am J Psychiatry; 2001 Oct; 158(10):1659-65. PubMed ID: 11578999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional pattern of increased water diffusivity in hippocampus and corpus callosum in mild cognitive impairment.
    Wang H; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(3):223-9. PubMed ID: 16900000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.
    Teipel SJ; Bayer W; Alexander GE; Bokde AL; Zebuhr Y; Teichberg D; Müller-Spahn F; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Neurobiol Aging; 2003; 24(1):85-94. PubMed ID: 12493554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
    Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
    Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.
    Hyman BT; West HL; Rebeck GW; Lai F; Mann DM
    Arch Neurol; 1995 Apr; 52(4):373-8. PubMed ID: 7710373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of neurones from cortical and subcortical areas in Down's syndrome patients at middle age. Quantitative comparisons with younger Down's patients and patients with Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B; Ravindra CR
    J Neurol Sci; 1987 Aug; 80(1):79-89. PubMed ID: 2956368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological correlates of hippocampal atrophy in memory testing in nondemented older adults.
    Vyhnalek M; Nikolai T; Andel R; Nedelska Z; Rubínová E; Marková H; Laczó J; Bezdicek O; Sheardova K; Hort J
    J Alzheimers Dis; 2014; 42 Suppl 3():S81-90. PubMed ID: 24670399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gross morphology and morphometric sequelae in the hippocampus, fornix, and corpus callosum of patients with severe non-missile traumatic brain injury without macroscopically detectable lesions: a T1 weighted MRI study.
    Tomaiuolo F; Carlesimo GA; Di Paola M; Petrides M; Fera F; Bonanni R; Formisano R; Pasqualetti P; Caltagirone C
    J Neurol Neurosurg Psychiatry; 2004 Sep; 75(9):1314-22. PubMed ID: 15314123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anterior commissure in Down's syndrome.
    Sylvester PE
    J Ment Defic Res; 1986 Mar; 30 ( Pt 1)():19-26. PubMed ID: 2939251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry.
    Raz N; Torres IJ; Briggs SD; Spencer WD; Thornton AE; Loken WJ; Gunning FM; McQuain JD; Driesen NR; Acker JD
    Neurology; 1995 Feb; 45(2):356-66. PubMed ID: 7854539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.